Agilent (A) Q3 FY25 earnings call

Agilent delivered strong Q3 FY25 results, with core revenue growth accelerating for the fifth consecutive quarter, driven by robust performance in Pharma and Chemicals & Advanced Materials. The company raised its full-year revenue guidance, reflecting confidence in continued momentum despite margin pressures from tariffs and increased investments. Management emphasized the effectiveness of its Ignite operating model in mitigating headwinds and driving future growth and market share gains.